Are you Dr. Baeten?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 74 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
325 9th Ave
Campus Box 359927
Seattle, WA 98104Phone+1 206-520-3808Fax+1 206-520-3801- Is this information wrong?
Summary
- Dr. Jared Baeten, MD is an infectious disease specialist in Seattle, Washington. He is currently licensed to practice medicine in Washington and Massachusetts. He is affiliated with UW Medicine/Harborview Medical Center and UW Medicine/University of Washington Medical Center.
Education & Training
- University of WashingtonFellowship, Infectious Disease, 2006 - 2008
- Massachusetts General HospitalResidency, Internal Medicine, 2003 - 2006
- University of Washington School of MedicineClass of 2003
Certifications & Licensure
- WA State Medical License 2006 - 2025
- MA State Medical License 2005 - 2008
- American Board of Internal Medicine Infectious Disease
Clinical Trials
- Trial to Study the Effect of Dose of Herpes Simplex Virus-2 (HSV-2) Suppressive Therapy on HSV and HIV Start of enrollment: 2007 Dec 01
- Pre-Exposure Prophylaxis to Prevent HIV-1 Acquisition Within HIV-1 Discordant Couples Start of enrollment: 2008 May 01
- Phase 3 Safety and Effectiveness Trial of Dapivirine Vaginal Ring for Prevention of HIV-1 in Women Start of enrollment: 2012 Jul 24
- Join now to see all
Publications & Presentations
PubMed
- HIV-1 Incidence, Adherence, and Drug Resistance in Individuals Taking Daily Emtricitabine/Tenofovir Disoproxil Fumarate for HIV-1 Pre-Exposure Prophylaxis: Pooled Anal...Raphael J Landovitz, Li Tao, Juan Yang, Melanie de Boer, Christoph Carter, Moupali Das, Jared M Baeten, Albert Liu, Karen W Hoover, Connie Celum, Beatriz Grinsztejn, S...> ;Clinical Infectious Diseases. 2024 Mar 14
- 1 citationsHIV Preexposure Prophylaxis With Emtricitabine and Tenofovir Disoproxil Fumarate Among Cisgender Women.Jeanne Marrazzo, Li Tao, Marissa Becker, Ashley A Leech, Allan W Taylor, Faith Ussery, Michael Kiragu, Sushena Reza-Paul, Janet Myers, Linda-Gail Bekker, Juan Yang, Ch...> ;JAMA. 2024 Mar 19
- Effect of differentiated direct-to-pharmacy PrEP refill visits supported with client HIV self-testing on clinic visit time and early PrEP continuation.Kidist Belay Zewdie, Kenneth Ngure, Margaret Mwangi, Dominic Mwangi, Simon Maina, Lydia Etyang, Gakuo Maina, Vallery Ogello, Emmah Owidi, Nelly R Mugo, Jared M Baeten,...> ;Journal of the International AIDS Society. 2024 Mar 1
- Join now to see all
Press Mentions
- Gilead Presents Positive Proof-of-Concept Data for Investigational Combination Regimen of Lenacapavir with Broadly Neutralizing Antibodies as a Potential Twice-Yearly Approach for the Treatment of HIVFebruary 22nd, 2023
- Investigational Lenacapavir Receives Positive CHMP Opinion for People with Multi-Drug Resistant HIVJune 24th, 2022
- New Clinical Data Support the Sustained Efficacy of Long-Acting Lenacapavir, Gilead’s Investigational HIV-1 Capsid InhibitorFebruary 16th, 2022
- Join now to see all
Grant Support
- PREP And Protective Immune Responses Against HIV-1National Institute Of Allergy And Infectious Diseases2012
- Evaluation Of Antiretroviral HIV Prevention In African HIV Discordant CouplesNational Institute Of Nursing Research2011–2012
- Optimizing Antiretroviral-Based HIV Prevention For HIV Serodiscordant CouplesNational Institute Of Mental Health2011
- Contraception, PREGNANCY, And HIV-1 Risk In African HIV-1 Serodiscordant CouplesEunice Kennedy Shriver National Institute Of Child Health &Human Development2011
Professional Memberships
- Member
Hospital Affiliations
- UW Medicine/University of Washington Medical CenterSeattle, Washington
- UW Medicine/Harborview Medical CenterSeattle, Washington